Twist Bioscience

Twist Bioscience Corporation is a biotechnology company based in South San Francisco, California, founded in 2013. It specializes in the scalable manufacturing of synthetic DNA using a proprietary silicon-based platform. The company went public in 2018 and has since expanded its operations, including the opening of a manufacturing facility in Wilsonville, Oregon, in 2022. Twist offers a range of products and services across three main business segments: Synthetic Biology, Next-Generation Sequencing Tools, and Biopharma Solutions. Its synthetic biology segment provides custom synthetic genes and DNA for various applications, including disease research and sustainable materials. The Next-Generation Sequencing Tools support cancer diagnostics and genetic testing, while the Biopharma Solutions focus on antibody discovery and drug development. Twist serves over 600 customers, including notable partners like Ginkgo Bioworks and Microsoft, highlighting its significant role in advancing synthetic biology and biotechnology infrastructure.